Mandelic 2 Peel Gel
NDC Package 70663-003-01
Package Information
Mandelic 2 Peel Gel is apply the content with a brush. Marketed by Meso System S.a., this product is identified by NDC 70663-003 and is authorized under FDA application part347.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70663 - Meso System S.a.
- 70663-003 - Mandelic 2 Peel Gel
- 70663-003-01 - 100 mL in 1 BOTTLE
- 70663-003 - Mandelic 2 Peel Gel
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70663-003-01 identifies a specific commercial package of 100 ml in 1 bottle of Mandelic 2 Peel Gel, labeled by Meso System S.a.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Meso System S.a. on October 05, 2016. The current certification is valid through December 31, 2019.
How is this Meso System S.a. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70663000301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.